Mitochondria-regulated formation of endothelium-derived extracellular vesicles shifts the mediator of flow-induced vasodilation

• Published in: American journal of physiology. Heart and circulatory physiology Vol. 312; no. 5; pp. H1096 - H1104
• Main Authors: Freed, Julie K, Durand, Matthew J, Hoffmann, Brian R, Densmore, John C, Greene, Andrew S, Gutterman, David D
• Format: Journal Article
• Language: English
• Published: United States American Physiological Society 01.05.2017
• Series: Vascular Biology and Microcirculation
• Subjects: Adipose Tissue - blood supply; Adipose Tissue - physiology; Antioxidants; Arteries; Arterioles - physiology; Blood Flow Velocity - physiology; Catalase; Cells; Chromatography; Composition effects; Endothelial cells; Endothelium; Endothelium, Vascular - physiology; Exposure; Extracellular vesicles; Extracellular Vesicles - physiology; Female; Flow cytometry; Flow resistance; Humans; Hydrogen peroxide; In Vitro Techniques; Liquid chromatography; Male; Mass spectrometry; Middle Aged; Mitochondria; Mitochondria - physiology; Nitric oxide; Phenylalanine; Proteins; Vasodilation; Vasodilation - physiology; Vesicles; endothelium; extracellular vesicles; vasodilation; mitochondria
• ISSN: 0363-6135; 1522-1539
• DOI: 10.1152/ajpheart.00680.2016

To examine the effect of endothelium-derived extracellular vesicles (eEVs) on the mediator of flow-induced dilation (FID), composition, formation, and functional effects on the mediator of FID were examined from two different eEV subtypes, one produced from ceramide, while the other was produced from plasminogen-activator inhibitor 1 (PAI-1). Using video microscopy, we measured internal-diameter changes in response to increases in flow in human adipose resistance arteries acutely exposed (30 min) to eEVs derived from cultured endothelial cells exposed to ceramide or PAI-1. FID was significantly impaired following exposure to 500K/ml (K = 1,000) of ceramide-induced eEVs (Cer-eEVs) but unaffected by 250K/ml. FID was reduced in the presence of PEG-catalase following administration of 250K/ml of Cer-eEVs and PAI-1 eEVs, whereas -nitro-l-arginine methyl ester (l-NAME) had no effect. Pathway analysis following protein composition examination using liquid chromatography tandem mass spectrometry (LC-MS/MS) demonstrated that both subtypes were strongly linked to similar biological functions, primarily, mitochondrial dysfunction. Flow cytometry was used to quantify eEVs in the presence or absence of l-phenylalanine-4'-boronic acid (PBA) and mitochondria-targeted [93-boronophenyl)methyl]triphenyl-phosphonium (mito-PBA), cytosolic and mitochondrial-targeted antioxidants, respectively. eEV formation was significantly and dramatically reduced with mito-PBA treatment. In conclusion, eEVs have a biphasic effect, with higher doses impairing and lower doses shifting the mediator of FID from nitric oxide (NO) to hydrogen peroxide (H O ). Despite differences in protein content, eEVs may alter vascular function in similar directions, regardless of the stimulus used for their formation. Furthermore, mitochondrial ROS production is required for the generation of these vesicles. The vascular effect of endothelium-derived extracellular vesicles (eEVs) is biphasic, with higher doses decreasing the magnitude of flow-induced dilation (FID) compared with lower doses that shift the mediator of FID from nitric oxide to H O eEVs may cause vascular dysfunction via similar pathways despite being formed from different stimuli, although both require mitochondrial reactive oxygen species for their formation.